Hey Justin
Sounds Promising, as a spine patient it all sounds so good![]()
Thanks
Gil![]()
This is a discussion on Aperius PercLID Stand Alone Interspinous System for the Treatment of Degenerative Lumbar Stenosis: Experience on 152 Cases within the Education, Research and Spine Publications forums, part of the General Spine Discussion Forums category; Journal of Spinal Disorders & Techniques . Volume 23(3), May 2010, pp 203-207 Nardi, PierVittorio MD; Cabezas, Daniel MD; Rea, ...
Journal of Spinal Disorders & Techniques. Volume 23(3), May 2010, pp 203-207
Nardi, PierVittorio MD; Cabezas, Daniel MD; Rea, Giancarla MD; Pettorini, Benedetta Ludovica MD. Neurosurgical Unit, Policlinico Casilino, Rome, Italy: Benedetta Ludovica Pettorini MD, Policlinico Casilino, Via Casilina 1049, Rome 00169, Italy. © 2010 Lippincott Williams & Wilkins, Inc.
Study Design: This study is a retrospective clinical investigation of a new interspinous device implanted via a totally percutaneous technique involving 152 consecutive patients.
Objective: Evaluation of the efficacy of the percutaneous Aperius stand alone implant in patients with degenerative lumbar stenosis and neurogenic intermittent claudication that did not respond to conservative treatment.
Summary of Background Data: The use of interspinous implants grew markedly during the last years. Nowadays, many extension controller devices are positioned through minimally invasive procedures.
Methods: From January 2007 to February 2008, 152 consecutive patients with neurogenic intermittent claudication were treated with Aperius PercLID system. Under a local anesthesia, a 1.5 cm skin incision was performed. Trocars for interspinous space distraction were positioned using fluoroscopy guidance. A suitable size Aperius was positioned and released in the interspinous space with a totally percutaneous technique. In 145 patients 1 level was treated, whereas 6 patients received 2 level treatments, and 1 patient received 3 level treatments. The levels treated were L4-L5 in 125 patients (78.2%), L3-L4 level in 26 patients (16.3%), L2-L3 level in 5 patients (3.1%), L5-S1 level in 3 patients (1.8%), and L1-L2 level in 1 patient (0.6%).
Results: The surgical time ranged from 8 to 14 minutes for 1 single level. No adverse events were noted. In 1 case (0.6%), Aperius was not implanted because of hypertrophic facet joints that have hindered the correct insertion of the device; we observed only 2 cases of therapeutic failure (1.3%). There was a significant improvement in the Visual Analog Scale and Zurich Claudication Questionnaire scores for low-back and leg pain and for neurogenic claudication.
Conclusions: These results indicate that Aperius PercLID system offers an easy, safe, and effective treatment for patients with lumbar degenerative stenosis. Thus, this device system treatment represents a valid alternative to the traditional surgical techniques.
Justin Averna
Founder & President, Spine Patient Society™
www.SpinePatientSociety.org
A 501(c)(3) Tax-Exempt Nonprofit & Charitable Organization
I'm here to help.
- 1994: Football Injury, Severe Hyperextension
- 1997: Snow Skiing Injury
- 3/7/1997: Laminotomy L4/L5
- 1999 & 2003: Motor Vehicle Accidents (not at fault both times) --> Grade V Annular Tears L4/L5 & L5/L6
- 11/15/2003: 2-Level ProDisc® L4/L5 & L5/L6*, *lumbosacral transitional vertebra --> Dr. Rudolf Bertagnoli
- 4/2008: 4.5 years pain-free before "new" leg pain
- 5/14/2009: Dynamic Stabilization System L4/L5, Dr. Rudolf Bertagnoli
Questions? Suggestions? Need help with registering, creating a signature, etc.?
justin (at) spinepatientsociety.org
Disclosure: I have no financial relationships with any surgeons, spine clinics, device manufacturers, pharmaceutical companies, hospitals, etc. -- the SPS Board of Directors serve without compensation.
Hey Justin
Sounds Promising, as a spine patient it all sounds so good![]()
Thanks
Gil![]()
L5-S1 lam 1994
L2 to L5 DDD
L3 -L4 hern Dec 2007.
L4-L5 Annular fissure with mild central stenosis and moderate facet hypertrophy.
L5-S1 bilaterial neural foraminal narrowing with inferior effacement.
L2-L3 Right-sided neural foraminal narrowing
L3-L4 related to posterolateral hypertrophic spurs and facet hypertrophy.
C3-C4 limited DDD
15 injections Depo. P.T. 18 months 9 dose packs,
Nerve Block Injections.4 ESI S1
L5-S1 Foraminotomy 09
L4-L5 Microdiscectomy 09 ReHerniation 4-2010
Surgery 6-29-11 L4-L5-S1 Decompression Fusion L5-S1 and Coflex F implants
Bookmarks